Winton Group LTD Spectrum Pharmaceuticals Inc Transaction History

Winton Group LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.38 - $1.07 $5,223 - $14,708	13,746 Added 14.41%	109,140 $81,000
Q4 2022 Feb 14, 2023	BUY	$0.32 - $0.52 $1,935 - $3,144	6,048 Added 6.77%	95,394 $35,000
Q3 2022 Nov 10, 2022	SELL	$0.43 - $1.56 $3,106 - $11,271	-7,225 Reduced 7.48%	89,346 $38,000
Q2 2022 Aug 10, 2022	BUY	$0.7 - $1.4 $48,616 - $97,232	69,452 Added 256.1%	96,571 $75,000
Q1 2022 May 11, 2022	BUY	$0.63 - $1.59 $17,084 - $43,119	27,119 New	27,119 $35,000
Q1 2020 May 11, 2020	SELL	$1.83 - $3.45 $23,477 - $44,260	-12,829 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$3.5 - $10.35 $44,901 - $132,780	12,829 New	12,829 $47,000
Q1 2019 May 13, 2019	SELL	$9.08 - $11.84 $133,503 - $174,083	-14,703 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$6.39 - $16.99 $93,952 - $249,803	14,703 New	14,703 $129,000
Q3 2018 Nov 02, 2018	SELL	$16.52 - $24.82 $239,325 - $359,567	-14,487 Closed	0 $0
Q2 2018 Aug 20, 2018	SELL	$14.31 - $21.75 $71,550 - $108,750	-5,000 Reduced 25.66%	14,487 $0
Q1 2018 May 21, 2018	BUY	$16.09 - $23.07 $313,545 - $449,565	19,487 New	19,487 $0
Q4 2017 Feb 13, 2018	SELL	$13.36 - $20.73 $3.1 Million - $4.81 Million	-231,947 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$8.75 - $14.07 $2.03 Million - $3.26 Million	231,947	231,947 $3.26 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.